CryoEM is revolutionizing the field of Structure based Drug Design. CryoEM can provide protein structures at the resolutions that are useful for drug discovery. However, CryoEM analysis workflow provides unique challenges for data handling, compute availability, automation, and orchestration. Clovertex is solving these unique challenges using the cloud-based scientific discovery platform for structural biologists, enabling a single click deployment in Customer’s VPC, enabling storing and processing cryo-EM data in the cloud in a scalable and cost-effective manner. The scientific discovery platform provides ability to analyze more structures in a short amount of time and reduce cost of analysis per structure without worrying about undifferentiated heavy lifting in IT infrastructure.